Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cediranib aims for a comeback.

× No keyword cloud information.

5 in total

Review 1. Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

Authors: Rakesh R Ramjiawan; Arjan W Griffioen; Dan G Duda
Journal: Angiogenesis Date: 2017-03-30 Impact factor: 9.596

Review 2. Recent advancements of antiangiogenic combination therapies in ovarian cancer.

Authors: Daniel An; Susana Banerjee; Jung-Min Lee
Journal: Cancer Treat Rev Date: 2021-05-19 Impact factor: 13.608

3. Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial.

Authors: R Paul Symonds; Charlie Gourley; Susan Davidson; Karen Carty; Elaine McCartney; Debbie Rai; Susana Banerjee; David Jackson; Rosemary Lord; Mary McCormack; Emma Hudson; Nicholas Reed; Maxine Flubacher; Petra Jankowska; Melanie Powell; Caroline Dive; Catharine M L West; James Paul
Journal: Lancet Oncol Date: 2015-10-22 Impact factor: 41.316

4. Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats.

Authors: Joanne J Carter; Laurice V Fretwell; Jeanette Woolard
Journal: FASEB J Date: 2016-12-16 Impact factor: 5.191

5. Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application.

Authors: Andrew Embleton-Thirsk; Elizabeth Deane; Stephen Townsend; Laura Farrelly; Babasola Popoola; Judith Parker; Gordon Rustin; Matthew Sydes; Mahesh Parmar; Jonathan Ledermann; Richard Kaplan
Journal: Clin Trials Date: 2019-07-26 Impact factor: 2.486

5 in total